Effect of narrative medicine combined with cooling blood and activating blood circulation on stigma and clinical efficacy in patients with psoriasis vulgaris

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005266

Enrollment

Unknown

Registered

2021-09-03

Start date

2021-09-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis vulgaris

Interventions

control group:cooling blood and activating blood circulation

experimental group:Narrative medicine combined with cooling blood and activating blood circulation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria of traditional Chinese and Western medicine for psoriasis vulgaris, and those who meet the various types of TCM syndrome differentiation; ? 2. Age between 18 and 60 years old; ? 3. The severity of the disease is moderate to severe, and the area of skin lesions is >= 10% of the body surface area; 4. SIS scale >= 48 points; 5. Those who voluntarily participated in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Joint, pustular, and erythrodermic psoriasis; ? 2. Pregnancy and lactation patients; 3. Patients with severe heart, liver, lung, kidney and other internal diseases and mental patients; 4. Those who are participating in other clinical trials.

Design outcomes

Primary

Measure	Time frame
psoriasis area and severity index;Social Impact Scale, SIS;	—

Secondary

Measure	Time frame
visual analogue scale;Therapeutic effect score of TCM Syndrome;	—

Countries

China

Contacts

Public ContactZhang Huina

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

396380317@qq.com+86 13693288039

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026